News

Study finds stigma drives depression in alopecia patients, rather than illness severity
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
Managed Healthcare Executive1d
New Alopecia Drug Offers Fast Hair Regrowth
Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...
Prevalence, incidence of eczema increase with severity of alopecia areata
Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), ...
Sun Pharma launches alopecia drug Leqselvi in US after settling patent dispute
Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...
Fierce Pharma2d
Sun Pharma's alopecia med Leqselvi hits US market after Incyte patent settlement
After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...
India's Sun Pharma launches hair loss drug Leqselvi in US after patent settlement
India's top drugmaker by revenue Sun Pharma on Monday launched its anti-baldness drug Leqselvi in the U.S., following the ...
TipRanks on MSN6d
AbbVie’s Promising Phase 3 Study on Upadacitinib for Alopecia Areata
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
Medscape6d
Primary Cicatricial Alopecia: Clinical Features and Management
Small areas of scarring alopecia gradually appear and may become extensive and impressive, leaving large areas of bare scalp with continued active disease at the periphery (see Figure 7).